Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01323699 · ClinicalTrials.gov registry record · Phase 1

Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease

A Phase 1 study, sponsored by Michael E. DeBakey VA Medical Center.

Completed
Registry status
Phase 1
Development phase
20
Enrollment target

NCT01323699 is a Phase 1 study that has completed, run by Michael E. DeBakey VA Medical Center. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01323699, a Phase 1 study, has completed, sponsored by Michael E. DeBakey VA Medical Center.

COMPLETED
Registry status
Phase 1
Development phase
20 participants
Enrollment target

Study Summary

Behavioral Treatments for Anxiety and Depression (BehTA-D) is a research study for anxiety and depression in individuals with Parkinson's disease (PD). The research clinicians try to teach skills that may help participants cope with anxiety and depression in the context of Parkinson's disease. Research clinicians will also discuss ways improve management of Parkinson's symptoms. Other skills taught include how to relax, change thinking, add in meaningful pleasant activity.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2011-11
Est. Completion 2013-02
Phase Phase 1

What the Registry Record Tells You About NCT01323699

The ClinicalTrials.gov registry entry for NCT01323699 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michael E. DeBakey VA Medical Center, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.

NCT01323699 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01323699 about?

NCT01323699 is a clinical study titled "Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease". Behavioral Treatments for Anxiety and Depression (BehTA-D) is a research study for anxiety and depression in individuals with Parkinson's disease (PD). The research clinicians try to teach skills that may help participants cope with anxiety and depression in the context of Parkinson's disease. Resea...

What is the current status of trial NCT01323699?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2011-11. Estimated completion is 2013-02.

What interventions are being tested in trial NCT01323699?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01323699?

This trial is sponsored by Michael E. DeBakey VA Medical Center, which has 16 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.